top of page

Currently Enrolling Studies

Vagus Nerve Stimulation (VNS Therapy System) for Treatment-Resistant Depression (TRD)
(Ages 18 years and older) 
Assessing Efficacy, Safety, and Tolerability of Two Administrations of COMP360 (a proprietary formulation of synthetic PSILOCYBIN) in Participants With Treatment-Resistant Depression (TRD)
(Ages 18 and older) 
Assessing Efficacy, Safety, and Tolerability of CYB003 (a proprietary formulation of synthetic PSILOCYBIN) as Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
(Ages 18-85)
  Please check back as more study enrollment opportunities will become available!
bottom of page